In vitro induction of resistance to metronidazole, and analysis of mutations in rdxA and frxA genes from Helicobacter pylori isolates

Journal of Infection and Chemotherapy

Volumn 11, Issue 2, 2005, Pages 59-63

  Perez Aldana, Luis ^a   Kato, Mototsugu ^b   Kondo, Takeshi ^a   Nakagawa, Souichi ^b   Zheng, Rinan ^a   Sugiyama, Toshio ^a   Asaka, Masahiro ^a   Kwon, Dong H ^c  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Helicobacter pylori; Metronidazole; rdxA frxA; Resistance

Indexed keywords

METRONIDAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; GENE FUNCTION; GENE INACTIVATION; GENE MUTATION; GENE SEQUENCE; HELICOBACTER PYLORI; NONHUMAN; SEQUENCE ANALYSIS;

EID: 18444417403     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-004-0370-y     Document Type: Article

References (44)

1. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997;10:720-41.
2. Megraud F, Lamouliatte H. Helicobacter pylori and duodenal ulcer evidence suggesting causation. Dig Dis Sci 1992;37:1278-82.
3. Parsonnet J, Hansen S, Rodriguez C, Gelb AB, Warnke RA, Jellum E, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-71.
4. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
5. American Digestive Health Foundation. The report of the digestive health initiative international update conference on Helicobacter pylori. Gastroenterology 1997;113:S4-8.
6. Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A, et al. Current concepts in the management of Helicobacter pylori infection. The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002;16:167-80.
7. Dore MP, Marras L, Maragkoudakis E, Nieddu S, Manca A, Graham DY, et al. Salvage therapy after two or more prior Helicobacter pylori treatment failures: the super salvage regimen. Helicobacter 2003;8:307-9.
8. Isomoto H, Inoue K, Furusu H, Enjoji A, Fujimoto C, Yamakawa M, et al. High-dose rabeprazole-amoxicillin versus rabeprazole-amoxicillin-metronidazole as a second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection. Aliment Pharmacol Ther 2003;18:101-7.
9. Graham DY, de Boer WA, Tytgat G. Choosing the best anti-Helicobacter pylori treatment: effect of antimicrobial resistance. Am J Gastroenterol 1996;91:1072-6.
10. Perez Aldana L, Kato M, Nakagawa S, Kawarasaki M, Nagasako T, Mizushima T, et al. The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance. Helicobacter 2002;7:306-9.
11. Mukhopadhyay AK, Kersulyte D, Jeong Y, Datta S, Ito Y, Chowdhury A, et al. Distinctiveness of genotypes of Helicobacter pylori in Calcutta, India. J Bacteriol 2000;182:3219-27.
12. Megraud F. Antibiotic resistance in Helicobacter pylori infection. Br Med Bull 1998;54:207-15.
13. Graham DY. Antibiotic resistance in Helicobacter pylori: implication for therapy. Gastroenterology 1998;115:1272-7.
14. Osato MS, Reddy R, Graham DY. Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States. Int J Antimicrob Agents 1999;12:341-7.
15. Jenks PJ, Ferrero RL, Labigne A. The role of the rdxA gene in the evolution of metronidazole resistance in Helicobacter pylori. J Antimicrob Chemother 1999;43:753-8.
16. Jeong JY, Mukhopadhyay A, Dailidiene D, Wang Y, Velapatino B, Gilman RH, et al. Sequencial inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes causes moderate and high-level metronidazole resistance in Helicobacter pylori. J Bacteriol 2000;182:5082-90.
17. Kwon DH, El Zaatari FA, Kato M, Osato MS, Reddy R, Yamaoka Y, et al. Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (frxA) and ferre-doxin-like protein (fdxB) in metronidazole resistance of Helicobacter pylori. Antimicrob Agents Chemother 2000;44:2133-42.
18. Tankovic J, Lamarque D, Delchier JC, Soussy CJ, Labigne A, Jenks PJ. Frequent association between alteration of the rdxA gene and metronidazole resistance in French and North African isolates of Helicobacter pylori. Antimicrob Agents Chemother 2000;44:608-13.
19. Goodwin A, Kersulyte D, Sisson G, Veldhuyzen van Zanten SJ, Berg DE, Hoffman PS. Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase. Mol Microbiol 1998;28:383-93.
20. Lindmark DG, Muller M. Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles. Antimicrob Agents Chemother 1976;10:476-82.
21. Jorgensen MA, Manos J, Mendz GL, Hazell SL. The mode of action of metronidazole in Helicobacter pylori: futile cycling or reduction. J Antimicrob Chemother 1998;41:67-75.
22. Kwon DH, Kato M, El-Zaatari FA, Osato MS, Graham DY. Frame-shift mutations in NADPH flavin oxidoreductase encoding gene (frxA) from metronidazole-resistant Helicobacter pylori ATCC43504 and its involvement in metronidazole resistance. FEMS Microbiol Lett 2000;188:197-202.
23. Bilardi C, Marais A, Cantet F. Characterization of the genes rdxA and frxA involved in metronidazole resistance in Helicobacter pylori. Res Microbiol 2003;154:137-44.
24. Jeong JY, Berg DE. Mouse-colonizing Helicobacter pylori SS1 is unusually susceptible to metronidazole due to two complementary reductase activities. Antimicrob Agents Chemother 2000;44:3127-32.
25. Mukhopadhyay AK, Jeong JY, Dailidiene D, Hoffman PS, Berg DE. The fdxA ferredoxin gene can down-regulate frxA nitroreductase gene expression and is essential in many strains of Helicobacter pylori. J Bacteriol 2003;185:2927-35.
26. Kaihovaara P, Hook-Nikanne J, Uusi-Oukari M, Kosunen TU, Salaspuro M. Flavodoxin-dependent pyruvate oxidation, acetate production and metronidazole reduction by Helicobacter pylori. J Antimicrob Chemother 1998;41:171-7.
27. Hughes NJ, Clayton CL, Chalk PA, Kelly DJ. Helicobacter pylori porCDAB and oorDABC genes encode distinct pyruvate:flavodoxin and 2-oxoglutarate: acceptor oxidoreductases which mediate electron transport to NADP. J Bacteriol 1998;180:1119-28.
28. Trend MA, Jorgensen MA, Hazell SL, Mendz GL. Oxidases and reductases involved in metronidazole sensitivity in Helicobacter pylori. Int J Biochem Cell Biol 2001;33:143-53.
29. Alm RA, Ling LS, Moir DT, King BL, Brown ED, Doig PC, et al. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 1999;397:176-80.
30. Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997;388:539-47.
31. Kwon DH, Hulten K, Kato M, Kim JJ, Lee M, El-Zaatari FA, et al. DNA sequence analysis of rdxA and frxA from 12 pairs of metronidazole-sensitive and resistant clinical Helicobacter pylori isolates. Antimicrob Agents Chemother 2001;45:2609-15.
32. Hachem CY, Clarridge JE, Evans DG, Graham DY. Comparison of agar based media for primary isolation of Helicobacter pylori. J Clin Pathol 1995;48:714-6.
33. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Approved standard M7-A5, informational supplement. Wayne. PA:NCCLS; 2000.
34. Haas CE, Nix DE, Schentag JJ. In vitro selection of resistant Helicobacter pylori. Antimicrob Agents Chemother 1990;34:1637-41.
35. Kwon DH, El-Zaatari FA, Woo JS, Perng CL, Graham DY, Go MF. REP-PCR fragments as biomarkers for differentiating gastroduodenal disease-specific Helicobacter pylori strains. Dig Dis Sci 1998;43:980-7.
36. Hulten K, Gibreel A, Skold O, Engstrand L. Macrolide resistance in Helicobacter pylori; mechanism and stability in strains from clarithromycin-treated patients. J Antimicrob Chemother 1997;43:753-8.
37. Pilotto A, Franceschi M, Rassu M, Leandro G, Bozzola L, Furlan F, et al. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study. Dig Liver Dis 2000;32:667-72.
38. Kwon DH, Pena JA, Osato MS, Fox JG, Graham DY, Versalovic J. Frameshift mutations in rdxA and metronidazole resistance in North American Helicobacter pylori isolates. J Antimicrob Chemother 2000;46:793-6.
39. Marais A, Bilardi C, Cantet F, Mendz GL, Megraud F. Characterization of the genes rdxA and frxA involved in metronidazole resistance in Helicobacter pylori. Res Microbiol 2003;154:137-44.
40. Paul R, Postius S, Melchers K, Schafer KP. Mutations of the Helicobacter pylori genes rdxA and pbp1 cause resistance against metronidazole and amoxicillin. Antimicrob Agents Chemother 2001;45:962-5.
41. Jeong JY, Mukhopadhyay AK, Akada JK, Dailidiene D, Hoffman PS, Berg DE. Roles of frxA and rdxA nitroreductases of Helicobacter pylori in susceptibility and resistance to metronidazole. J Bacteriol 2001;183:5155-62.
42. Bereswill S, Krainick C, Stahler F, Herrmann L, Kist M. Analysis of the rdxA gene in high-level metronidazole-resistant clinical isolates confirms a limited use of rdxa mutations as a marker for prediction of metronidazole resistance in Helicobacter pylori. FEMS Immunol Med Microbiol 2003;36:193-8.
43. Mendz G, Megraud F. Is the molecular basis of metronidazole resistance in microaerophilic organisms understood?. Trends Microbiol 2002;10:370-5.
44. Solca NM, Bernasconi MV, Piffaretti JC. Mechanism of metronidazole resistance in Helicobacter pylori: comparison of the rdxA gene sequence in 30 strains. Antimicrob Agents Chemother 2000;44:2207-10.